Molecular interactions between matrilysin and the matrix metalloproteinase inhibitor doxycycline investigated by deuterium exchange mass spectrometry

Molecular Pharmacology

Volumn 67, Issue 4, 2005, Pages 1128-1136

  García, Ricardo A ^a   Pantazatos, Dennis P ^a   Gessner, Christopher R ^a   Go, Katrina V ^a   Woods Jr , Virgil L ^a   Villarreal, Francisco J ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOXYCYCLINE; MATRILYSIN; MATRIX METALLOPROTEINASE INHIBITOR; POTASSIUM IODIDE;

ARTICLE; BINDING SITE; CRYSTAL STRUCTURE; DEUTERIUM EXCHANGE MASS SPECTROMETRY; DEUTERIUM HYDROGEN EXCHANGE; ENZYME INHIBITION; ENZYME SPECIFICITY; EQUILIBRIUM DIALYSIS; EXTRACELLULAR MATRIX; MASS SPECTROMETRY; MOLECULAR INTERACTION; MORPHOGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN STRUCTURE; STOICHIOMETRY; X RAY CRYSTALLOGRAPHY;

BINDING SITES; DEUTERIUM EXCHANGE MEASUREMENT; DOXYCYCLINE; FLUORESCENCE; MASS SPECTROMETRY; MATRIX METALLOPROTEINASE 7; MATRIX METALLOPROTEINASES; PROTEASE INHIBITORS;

EID: 15744389578     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.104.006346     Document Type: Article

References (40)

1. Adachi Y, Yamamoto H, Itoh F, Hinoda Y, Okada Y, and Imai K (1999) Contribution of matrilysin (MMP-7) to the metastatic pathway of human colorectal cancers. Gut 42:252-258.
2. Boixel C, Fontaine V, Rucker-Martin C, Milliez P, Louedec L, Michel JB, Jacob MP, and Hatem SN (2003) Fibrosis of the left atria during progression of heart failure is associated with increased matrix metalloproteinases in the rat. J Am Coll Cardiol 42:336-342.
3. Browner MF, Smith WW, and Castelhano AL (1995) Matrilysin-inhibitor complexes: common themes among metalloproteases. Biochemistry 34:6602-6610.
4. Crawford HC, Scoggins CR, Washington MK, Matrisian LM, and Leach SD (2002) Matrix metalloproteinase-7 is expressed by pancreatic cancer precursors and regulates acinar-to-ductal metaplasia in exocrine pancreas. J Clin Investig 109: 1437-1444.
5. Davies G, Jiang WG, and Mason MD (2001) Matrilysin mediates extracellular cleavage of E-cadherin from prostate cancer cells: a key mechanism in hepatocyte growth factor/scatter factor-induced cell-cell dissociation and in vitro invasion. Clin Cancer Res 7:3289-3297.
6. Egeblad M and Werb Z (2002) New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 3:161-174.
7. Fu X, Kassim SY, Parks WC, and Heinecke JW (2001) Hypochlorous acid generated by myeloperoxidase modifies adjacent tryptophan and glycine residues in the catalytic domain of matrix metalloproteinase-7: an oxidative mechanism for restraining protease activity during inflammation. J Biol Chem 276:41279-41287.
8. Hamuro Y, Wong L, Shaffer J, Kim JS, Jennings PA, Adams JA, and Woods VL Jr (2002a) Phosphorylation-driven motion in the COOH-terminal Src kinase, Csk, revealed through enhanced hydrogen-deuterium exchange and mass spectrometry (DXMS). J Mol Biol 323:871-881.
9. Hamuro Y, Zawadzki KM, Kim JS, Stranz D, Taylor SS, and Woods VL Jr (2003) Dynamics of cAPK type IIb activation revealed by enhanced amide H/2H exchange mass spectrometry (DXMS). J Mol Biol 327:1065-1076.
10. Hamuro Y, Zawadzki K, Kim JS, Taylor SS, and Woods VL Jr (2002b) Dynamics of protein kinase A regulatory subunit studied by enhanced hydrogen deuterium exchange-mass spectrometry (DXMS). Protein Sci 11:84.
11. Heppner KJ, Matrisian LM, Jensen RA, and Rodgers WH (1996) Expression of most matrix metalloproteinase family members in breast cancer represents a tumor-induced host response. Am J Pathol 149:273-282.
12. Khan MA, Muzammil S, and Musarrat J (2002) Differential binding of tetracyclines with serum albumin and induced structural alterations in drug-bound protein. Int J Biol Macromol 30:243-249.
13. 2+ reveals mechanism of antibiotic resistance. J Mol Biol 247:260-280.
14. Kivela-Rajamaki M, Maisi P, Srinivas R, Tervahartiala T, Teronen O, Husa V, Salo T, and Sorsa T (2003) Levels and molecular forms of MMP-7 (matrilysin-1) and MMP-8 (collagenase-2) in diseased human peri-implant sulcular fluid. J Periodontal Res 38:583-590.
15. Lakowicz JR (1983) Principles of Fluorescence Spectroscopy. Plenum Press, New York.
16. Lindsey M (2004) MMP induction and inhibition in myocardial infarction. Heart Fail Rev 9:7-19.
17. Lowry CL, McGeehan G, and LeVine H (1992) Metal ion stabilization of the conformation of a recombinant 19-kDa catalytic fragment of human fibroblast collagenase. Proteins 12:42-48.
18. Matsuno K, Adachi Y, Yamamoto H, Goto A, Arimura Y, Endo T, Itoh F, and Imai K (2003) The expression of matrix metalloproteinase matrilysin indicates the degree of inflammation in ulcerative colitis. J Gastroenterol 38:348-354.
19. Miller EJ and Rhodes RK (1982) Preparation and characterization of the different types of collagen. Methods Enzymol 82:33-64.
20. Nagase H (1997) Activation mechanisms of matrix metalloproteinases. Biol Chem 378:151-160.
21. Okamoto T, Akaike T, Sawa T, Miyamoto Y, vanderVliet A and Maeda H (2001) Activation of matrix metalloproteinases by peroxynitrite-induced protein S-glutathiolation via disulfide S-oxide formation. J Biol Chem 276:29596-29602.
22. Onoda T, Ono T, Dhar DK, Yamanoi A, Fujii T, and Nagasue N (2004) Doxycycline inhibits cell proliferation and invasive potential: combination therapy with cyclo-oxygenase-2 inhibitor in human colorectal cancer cells. J Lab Clin Med 143:207-216.
23. Pantazatos D, Kim JS, Klock HE, Stevens RC, Wilson IA, Lesley SA, and Woods VL Jr (2004) Rapid refinement of crystallographic protein construct definition employing enhanced hydrogen/deuterium exchange mass spectrometry (DXMS). Proc Natl Acad Sci USA 101:751-756.
24. Peterson JT (2004) Matrix metalloproteinase inhibitor development and the remodeling of drug discovery. Heart Fail Rev 9:63-79.
25. Ryan ME, Ramamurthy S, and Golub LM (1996) Matrix metalloproteinases and their inhibition in periodontal treatment. Curr Opin Periodontol 3:85-96.
26. Schneider S (2001) Proton and metal ion binding by tetracyclines, in Tetracyclines in Biology, Chemistry and Medicine (Nelson M, Hillen W and Greenwald RA eds) pp 65-104, Birkhauser Verlag, Basel, Switzerland.
27. Seftor RE, Seftor EA, DeLarco JE, Kleiner DE, Leferson J, Stetler-Stevenson WG, McNamara TF, Golub LM, and Hendrix MJ (1998) Chemically modified tetracyclines inhibit human melanoma cell invasion and metastasis. Clin Exp Metastasis 16:217-225.
28. Smith GN Jr, Brandt KD, and Hasty KA (1996) Activation of recombinant human neutrophil procollagenase in the presence of doxycycline results in fragmentation of the enzyme and loss of enzyme activity. Arthritis Rheum 39.
29. Smith GN Jr, Mickler EA, Hasty KA, and Brandt KD (1999) Specificity of inhibition of matrix metalloproteinase activity by doxycycline: relationship to structure of the enzyme. Arthritis Rheum 42:1140-1146.
30. Suter P and Rosenbusch JP (1977) Determination of the Donnan effect in equilibrium dialysis and a simple method for its correction. Anal Biochem 82:109-114.
31. Takahashi M, Altschmied L, and Hillen W (1986) Kinetic and equilibrium characterization of the Tet repressor-tetracycline complex by fluorescence measurements. Evidence for divalent metal ion requirement and energy transfer. J Mol Biol 187:341-348.
32. Thompson RW and Baxter BT (1999) MMP inhibition in abdominal aortic aneurysms. Rationale for a prospective randomized clinical trial. Ann NY Acad Sci 878:159-178.
33. Villarreal FJ, Griffin M, Omens J, Dillmann W, Nguyen J, and Covell J (2003) Circulation. 108 12:1487-1492.
34. Visse R and Nagase H (2003) Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function and biochemistry. Circ Res 92:827-839.
35. Wart HEV and Birkedal-Hansen H (1990) The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family. Proc Natl Acad Sci USA 87:5578-5582.
36. Willenbrock F, Murphy G, Phillips IR, and Brocklehurst K (1995) The second zinc atom in the matrix metalloproteinase catalytic domain is absent in the full-length enzymes: a possible role for the C-terminal domain. FEBS Lett 358:189-192.
37. Wilson CL, Heppner KJ, Labosky PA, Hogan BL, and Matrisian LM (1997) Intestinal tumorigenesis is suppressed in mice lacking the metalloproteinase matrilysin. Proc Natl Acad Sci USA 94:1402-1407.
38. Woods VL Jr (2002) High resolution, high throughput amide deuterium exchange-mass spectrometry (DXMS) determination of the dynamics and structure of protein-protein interactions. J Am Soc Mass Spectrom 13:14S.
39. Woods VL Jr and Hamuro Y (2001) High-resolution, high-throughput amide deuterium exchange-mass speetrometry (DXMS) determination of protein binding site structure and dynamics: utility in pharmaceutical design. J Cell Biockem 37:89-98.
40. Yamamoto T, Izumi S, and Gekko K (2004) Mass spectrometry on hydrogen/deuterium exchange of dihydrofolate reductase: effects of ligand binding. J Biochem (Tokyo) 135:633-671.